dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Howe, Anita |
dc.contributor.author | Rodrigo, Chaturaka |
dc.contributor.author | Cunningham, Evan Brian |
dc.contributor.author | Douglas, Mark W. |
dc.contributor.author | Dietz, Julia |
dc.contributor.author | Grebely, Jason |
dc.contributor.author | Quer Sivila, Josep |
dc.date.accessioned | 2022-08-19T11:14:05Z |
dc.date.available | 2022-08-19T11:14:05Z |
dc.date.issued | 2022-05 |
dc.identifier.citation | Howe AYM, Rodrigo C, Cunningham EB, Douglas MW, Dietz J, Grebely J, et al. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals. JHEP Rep. 2022 May;4(5):100462. |
dc.identifier.issn | 2589-5559 |
dc.identifier.uri | https://hdl.handle.net/11351/8024 |
dc.description | Fracàs virològic; Hepatitis C |
dc.description.sponsorship | The initial SHARED development was funded in part by Merck and a User Partnership Program grant from Genome British Columbia to P.R.H and A.Y.M.H (UPP029). The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian (or any other) Government. C.R. and J.G. are supported by an NHMRC Investigator Grant (nos. 1173666, 1176131). An NHMRC Program Grant supported RAS testing and data collection by M.W.D. (1053206) and small grants from the Australian Centre for HIV and Hepatitis Virology Research, The University of Sydney, Western Sydney Local Health District Research Education Network, and the Robert W. Storr bequest to the Sydney Medical Foundation (University of Sydney). S.P. received personal fees from Gilead Sciences. Regarding the Italian data, the work was supported in part by the Italian Ministry of Instruction, University and Research (MIUR) (Bandiera InterOmics Protocollo PB05 1°), by the Italian Ministry of Health (RF-2016-02362422), and by Aviralia and Vironet C Foundations. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | JHEP Reports;4(5) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Medicaments antivírics |
dc.subject | Resistència als medicaments |
dc.subject | Hepatitis C |
dc.subject.mesh | Antiviral Agents |
dc.subject.mesh | Drug Resistance, Viral |
dc.subject.mesh | Hepatitis C |
dc.title | Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.jhepr.2022.100462 |
dc.subject.decs | antivíricos |
dc.subject.decs | farmacorresistencia viral |
dc.subject.decs | hepatitis C |
dc.relation.publishversion | https://doi.org/10.1016/j.jhepr.2022.100462 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Howe AYM] British Columbia Centre for Disease Control, British Columbia, Canada. [Rodrigo C] School of Medical Sciences, UNSW Sydney, Sydney, Australia. [Cunningham EB, Grebely J] The Kirby Institute, UNSW Sydney, Sydney, Australia. [Douglas MW] Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney at Westmead Hospital, Westmead, Australia. [Dietz J] Department of Internal Medicine 1, University Hospital, Goethe University, Frankfurt, Germany. [Quer J] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBEREHD, Barcelona, Spain |
dc.identifier.pmid | 35434589 |
dc.identifier.wos | 000795853800010 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |